Filing Details
- Accession Number:
- 0001437749-21-014027
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-06-03 08:39:35
- Reporting Period:
- 2021-04-02
- Accepted Time:
- 2021-06-03 08:39:35
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1653821 | Cen Biotech Inc | CENBF | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1736940 | Richard Boswell | 300-3295 Quality Way Windsor, Ontario, Canada A6 N8T 3R9 | Senior Executive Vp | Yes | Yes | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2021-01-26 | 37,500 | $0.40 | 6,000,000 | No | 4 | S | Direct | |
Common Stock | Disposition | 2021-01-27 | 6,250 | $0.80 | 6,000,000 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2021-04-02 | 2,185,679 | $0.00 | 6,000,000 | No | 4 | A | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | A | Direct |
Footnotes
- 2,185,679 shares of common stock of issuer were granted by the issuer on April 2, 2021, pursuant to a restricted stock agreement pursuant to the issuer's equity compensation plan and the issuance was approved by the issuer's full board of directors.